Endometrial Cancer (MSI-High) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Endometrial Cancer (MSI-High)
Endometrial cancer with high microsatellite instability (MSI-High) is a specific type of uterine cancer with unique genetic features that influence treatment. Understanding this diagnosis is crucial for effective care. TheDrugClub is dedicated to helping patients manage the often high costs of essential prescription medications, ensuring access to the treatments you need to fight this condition.
Endometrial cancer, originating in the lining of the uterus, is one of the most common gynecologic cancers. While all endometrial cancers require careful management, a significant subset is characterized by a feature known as Microsatellite Instability-High (MSI-High).
What is Endometrial Cancer MSI-High?
Microsatellites are short, repeating DNA sequences. In healthy cells, a system of DNA repair proteins corrects errors that occur during DNA replication. However, in MSI-High cancers, these repair mechanisms are faulty. This leads to an accumulation of errors within the microsatellite regions, making the tumor genetically unstable. Approximately 20-30% of endometrial cancers are MSI-High. This genetic characteristic is incredibly important because it often predicts how a tumor will respond to certain treatments, particularly immunotherapies.
Common Treatments and Medications for MSI-High Endometrial Cancer
Treatment for endometrial cancer typically begins with surgery, often followed by radiation therapy or chemotherapy, depending on the stage and other factors. For patients with MSI-High endometrial cancer, especially in advanced or recurrent cases, immunotherapy has emerged as a powerful and often preferred option. Medications like pembrolizumab (Keytruda®) and dostarlimab (Jemperli®) are examples of immunotherapies approved to treat MSI-High endometrial cancer. These drugs work by harnessing the body's immune system to recognize and attack cancer cells. While highly effective for many, these advanced treatments can come with a substantial price tag, creating a significant financial burden for patients and their families.
How TheDrugClub Helps You Save on Prescriptions
Managing the cost of prescriptions, especially for long-term or specialized treatments like immunotherapies, can be overwhelming. This is where TheDrugClub steps in. For a low monthly membership fee – just $19.95 for individuals or $39.95 for families – you gain access
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.